Avantax Advisory Services, Inc. Organon & Co. Transaction History

Avantax Advisory Services, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$19.27 - $24.63 $3,410 - $4,359	-177 Reduced 1.55%	11,225 $233,000
Q1 2023 Apr 28, 2023	BUY	$21.42 - $32.08 $6,683 - $10,008	312 Added 2.81%	11,402 $268,000
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $10,233 - $12,559	-439 Reduced 3.81%	11,090 $309,000
Q3 2022 Nov 01, 2022	SELL	$23.4 - $34.25 $47,899 - $70,109	-2,047 Reduced 15.08%	11,529 $270,000
Q2 2022 Aug 02, 2022	BUY	$31.66 - $38.9 $46,381 - $56,988	1,465 Added 12.1%	13,576 $458,000
Q1 2022 Apr 27, 2022	BUY	$30.45 - $39.36 $3,775 - $4,880	124 Added 1.03%	12,111 $404,000
Q4 2021 Jan 24, 2022	BUY	$28.67 - $37.13 $31,364 - $40,620	1,094 Added 10.04%	11,987 $365,000
Q3 2021 Oct 21, 2021	BUY	$28.63 - $35.64 $2,404 - $2,993	84 Added 0.78%	10,893 $325,000
Q2 2021 Jul 29, 2021	BUY	$28.45 - $38.0 $307,516 - $410,742	10,809 New	10,809 $292,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Advisory Services, Inc. with notifications on news.